药物对比
Tolbutamide vs Troglitazone
Tolbutamide作为磺脲类药物刺激胰岛素分泌；Troglitazone是一种已撤市的噻唑烷二酮类（TZD），可改善胰岛素敏感性但引起肝毒性。两者治疗2型糖尿病均已过时。
此页面暂无可用的对比维度。
临床背景
Historical review of first-generation sulfonylurea versus withdrawn thiazolidinedione for type 2 diabetes patients.
结论
Tolbutamide is still available as an older agent while Troglitazone was withdrawn for safety, so neither is first-line today.
全部药物对比